首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1623666

淋巴水腫治療市場規模、佔有率、成長分析，依治療類型、受影響區域、年齡層、給藥途徑、分銷管道、最終用戶、地區產業預測，2025-2032 年

Lymphedema Treatment Market Size, Share, Growth Analysis, By Treatment Type, By Type, By Affected Area, By Age Group, By Route Of Administration, By Distribution Channel, By End User, By Region - Industry Forecast 2025-2032

出版日期: 2024年12月25日 | 出版商:

SkyQuest | 英文 165 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2023年，淋巴水腫治療市場規模為8,6,014萬美元，從2024年的9,4,185萬美元成長到2032年的190.22萬美元，預計年複合成長率為9.5%。

由於多種因素，包括乳癌發生率的上升和癌症倖存者中淋巴水腫的盛行率，淋巴水腫治療市場正在顯著成長。具體來說，40% 接受乳癌治療的女性會出現淋巴水腫，這種情況可能在治療後立即出現，也可能在幾十年後出現。此病主要影響下肢，在婦科癌症患者中發生率較高。主要市場參與企業的技術進步和產品創新也推動了對有效淋巴水腫治療解決方案的需求。由於許多患者都經歷淋巴水腫的衰弱影響，尤其是在手術後，尖端癌症治療方法的持續發展對於緩解這種情況和擴大市場機會至關重要。

Bio Compression Systems
Tactile Medical
Medi
Lympha Press
Sigvaris
BSN Medical
L&R USA Inc.
Devon Medical Products
3M Health Care
JOBST USA
Thuasne
Wright Therapy Products
BioHorizons IPH, Inc.
Haddenham Healthcare
ArjoHuntleigh
Paul Hartmann
Bioventus
Baxter International Inc.
CircAid Medical Products, Inc.
Essity Aktiebolag

結論和建議

簡介目錄

Product Code: SQMIG35G2213

Lymphedema Treatment Market size was valued at USD 860.14 Million in 2023 and is poised to grow from USD 941.85 Million in 2024 to USD 1900.22 Million by 2032, growing at a CAGR of 9.5% during the forecast period (2025-2032).

The lymphedema treatment market is experiencing significant growth, driven by several factors including the rising incidence of breast cancer and the prevalence of lymphedema among cancer survivors. Notably, 40% of women undergoing breast cancer treatment develop lymphedema, which can manifest soon after treatment or even decades later. The disorder primarily affects the lower extremities and has higher occurrences among gynecologic cancer patients. The demand for effective lymphedema treatment solutions is also fueled by advancements in technology and product innovation from major market players. With a substantial patient population experiencing lymphedema's debilitating effects, particularly post-surgery, ongoing development of cutting-edge cancer therapies is critical to mitigating this condition and expanding market opportunities.

Top-down and bottom-up approaches were used to estimate and validate the size of the Lymphedema Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Lymphedema Treatment Market Segmental Analysis

Global Lymphedema Treatment Market is segmented by treatment type, type, affected area, age group, route of administration, distribution channel, end user and region. Based on treatment type, the market is segmented intoCompression Therapy, surgery, drug therapy, laser therapy and others. Based on type, the market is segmented into secondary lymphedema and primary lymphedema. Based on affected area, the market is segmented into lower extremity, upper extremity and genitalia. Based on age group, the market is segmented into adult, geriatric and pediatric. Based on route of administration, the market is segmented into oral, injectable and topical. Based on distribution channel, the market is segmented into pharmacy stores, direct tender and others. Based on end user, the market is segmented into hospital, speciality clinics, ambulatory surgical centers and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Lymphedema Treatment Market

The lymphedema treatment market is expected to grow significantly due to the rising incidence of lymphedema and breast cancer. An increase in cancer cases presents vast opportunities for market expansion. Coupled with surging health expenditures and heightened investments in drug discovery and development, demand for healthcare facilities is on the rise. Furthermore, the anticipated emergence of innovative lymphedema treatment options is likely to drive market growth during the forecast period. Technological advancements in treatment methodologies will also contribute to this upward trend. Additionally, government initiatives and favorable reimbursement policies are set to support the market's expansion.

Restraints in the Lymphedema Treatment Market

The Lymphedema Treatment market faces notable restraints that may hinder its growth. Despite technological advancements in the field, there remains no definitive cure for lymphedema, which poses a significant challenge to market development. Furthermore, the considerable expenses associated with various procedures and treatment options are anticipated to deter potential patients and healthcare providers, ultimately affecting overall market expansion. The combination of the lack of a permanent solution and the financial burden of managing lymphedema underscores the need for continued research and innovation to address these limitations and improve patient access to effective treatments.

Market Trends of the Lymphedema Treatment Market

The lymphedema treatment market is poised for significant growth, driven by an increasing prevalence of the condition and expanding awareness among healthcare providers and patients. Innovative therapies and advanced technologies are emerging at a rapid pace, enhancing treatment efficacy and patient safety. Rising healthcare expenditures globally are further propelling market expansion, alongside ongoing advancements in healthcare innovation that focus on personalized treatment options. Additionally, pharmaceutical companies are introducing cutting-edge medical devices, which are not only improving treatment outcomes but also stimulating market dynamics on a global scale, thereby positioning the lymphedema treatment market for sustained growth in the coming years.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Study Analysis

Global Lymphedema Treatment Market Size by Treatment Type & CAGR (2025-2032)

Market Overview
Compression Therapy
Surgery
Drug Therapy
Laser Therapy
Others

Global Lymphedema Treatment Market Size by Type & CAGR (2025-2032)

Market Overview
Secondary Lymphedema
Primary Lymphedema

Global Lymphedema Treatment Market Size by Affected Area & CAGR (2025-2032)

Market Overview
Lower Extremity
Upper Extremity
Genitalia

Global Lymphedema Treatment Market Size by Age Group & CAGR (2025-2032)

Market Overview
Adult
Geriatric
Pediatric

Global Lymphedema Treatment Market Size by Route Of Administration & CAGR (2025-2032)

Market Overview
Oral
Injectable
Topical

Global Lymphedema Treatment Market Size by Distribution Channel & CAGR (2025-2032)

Market Overview
Pharmacy Stores
Direct Tender
Others

Global Lymphedema Treatment Market Size by End User & CAGR (2025-2032)

Market Overview
Hospital
Speciality Clinics
Ambulatory Surgical Centers
Others

Global Lymphedema Treatment Market Size & CAGR (2025-2032)

North America (Treatment Type, Type, Affected Area, Age Group, Route Of Administration, Distribution Channel, End User)
- US
- Canada
Europe (Treatment Type, Type, Affected Area, Age Group, Route Of Administration, Distribution Channel, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Treatment Type, Type, Affected Area, Age Group, Route Of Administration, Distribution Channel, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Treatment Type, Type, Affected Area, Age Group, Route Of Administration, Distribution Channel, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Treatment Type, Type, Affected Area, Age Group, Route Of Administration, Distribution Channel, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2024
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2024
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

Bio Compression Systems
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Tactile Medical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medi
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lympha Press
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sigvaris
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BSN Medical
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
L&R USA Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Devon Medical Products
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
3M Health Care
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
JOBST USA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thuasne
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Wright Therapy Products
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioHorizons IPH, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Haddenham Healthcare
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ArjoHuntleigh
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Paul Hartmann
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bioventus
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Baxter International Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CircAid Medical Products, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Essity Aktiebolag
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments